Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the rectum - Page 3 of 4 Posts on Medivizor
Navigation Menu

Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the rectum Posts on Medivizor

Does administration of capecitabine and oxaliplatin both before and alongside radiotherapy improve cancer outcomes?

Posted by on Jul 14, 2014 in Colorectal cancer | 0 comments

In a nutshell The authors evaluated the short term effectiveness and safety of capecitabine and oxaliplatin administered prior to and then alongside radiotherapy for high-risk locally advanced rectal cancer. Some background Although neoadjuvant (before surgery) chemoradiotherapy has signifcantly reduced the risk of local...

Read More

Do circulating tumor cell markers of have both prognostic and predictive values?

Posted by on May 18, 2014 in Colorectal cancer | 0 comments

In a nutshell This study evaluated markers of circulating tumor cells as prognostic factors and predictive factors in patients with metastatic colorectal cancer. Some background Metastatic colorectal cancer (mCRC) is cancer whereby tumor cells have spread from the colon or rectum to other organs and tissues. The cells that escape from...

Read More

Does chemotherapy-induced neutropenia improve survival in metastatic colorectal cancer?

Posted by on Apr 16, 2014 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether chemotherapy-induced neutropenia improves survival of patients with metastatic colorectal cancer. Some background Metastatic colorectal cancer is colorectal cancer that has spread to other parts of the body. For unresectable (cannot be surgically removed) metastatic colorectal cancer, chemotherapy is...

Read More

Increasing response to treatment with statins

Posted by on Dec 13, 2013 in Colorectal cancer | 0 comments

In a nutshell This study examined whether statin use during cancer treatments can increase response rates and outcomes among rectal cancer patients before surgery. Some background Chemoradiation (chemotherapy and/or radiotherapy) is often used among rectal cancer patients before undergoing surgery (referred to as neoadjuvant therapy). Neoadjuvant...

Read More

NSAIDs and cancer

Posted by on Oct 9, 2013 in Colorectal cancer | 0 comments

In a nutshell This review analyzed a number of studies which evaluated the effect of non-steroidal anti-inflammatory drugs (NSAIDs) on cancers of the gastrointestinal system, such as colorectal cancer. Some background NSAIDs, such as aspirin and ibuprofen (Advil), are a class of drugs commonly used for pain relief and fever reduction. NSAIDs exert...

Read More

The addition of ganitumab or conatumumab to chemotherapy in the treatment of metastatic colorectal cancer

Posted by on Jul 19, 2013 in Colorectal cancer | 0 comments

In a nutshell This study compared the ability of two drugs, ganitumab and conatumumab, to treat patients with metastatic colorectal cancer when added to chemotherapy. Some background Cancer cells express various structures on their surface (called receptors) that may stimulate growth and help avoid destruction by the immune system. Drugs that...

Read More

Comparing combined versus sequential chemotherapy for patients with advanced colorectal cancer

Posted by on Jun 26, 2013 in Colorectal cancer | 0 comments

In a nutshell This trial compared the effect on disease progression and survival of different chemotherapy combinations used in the treatment of patients with metastatic colorectal cancer.  Some background Metastatic colorectal cancer (mCRC) is cancer that has spread from the large intestine to other organs and tissues. Chemotherapy...

Read More

Comparing the outcomes of laparoscopic versus open surgery in patients with colorectal cancer

Posted by on May 9, 2013 in Colorectal cancer | 0 comments

In a nutshell This study compared the short- and long-term outcomes of two types of surgery for patients with colorectal cancer (CRC): open surgery (OS) versus laparoscopic surgery (LS). LS led to less pain following surgery, shorter hospital stays, faster recovery times, and improved survival rates. Some background CRC is very common,...

Read More